KMT5A and breast carcinoma: Furthermore, the metastatic breast cancer cell lines (4T1, BT549, and MDA-MB-231) expressed higher levels of KMT5A than those of non-metastatic breast cancer cell lines (MDA-MB-453, MCF7, T47D, and BT474) (Supplementary Fig. 3d).